ReP USP - Resultado da busca

Trabalho de evento-resumo
Melanoma clonal heterogeneity underlies resistance to BRAF inhibitor (2014)
Tiago, Manoela; Paraiso, Kim; Phadke, Manali; Fedorenko, Inna V; Rebecca, Vito William; Alicea, Gretchen; Maria-Engler, Silvya Stuchi ; Smalley, Keiran S
Source: Abstracts. Conference titles: Moffitt Scientific Symposium. Unidade: FCF
Assunto: MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIAGO, Manoela et al. Melanoma clonal heterogeneity underlies resistance to BRAF inhibitor. 2014, Anais.. Tampa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2014. . Acesso em: 17 nov. 2024.
APA
Tiago, M., Paraiso, K., Phadke, M., Fedorenko, I. V., Rebecca, V. W., Alicea, G., et al. (2014). Melanoma clonal heterogeneity underlies resistance to BRAF inhibitor. In Abstracts. Tampa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Tiago M, Paraiso K, Phadke M, Fedorenko IV, Rebecca VW, Alicea G, Maria-Engler SS, Smalley KS. Melanoma clonal heterogeneity underlies resistance to BRAF inhibitor. Abstracts. 2014 ;[citado 2024 nov. 17 ]
Vancouver
Tiago M, Paraiso K, Phadke M, Fedorenko IV, Rebecca VW, Alicea G, Maria-Engler SS, Smalley KS. Melanoma clonal heterogeneity underlies resistance to BRAF inhibitor. Abstracts. 2014 ;[citado 2024 nov. 17 ]
Artigo de periodico
Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma (2014)
Rebecca, Vito William; Massaro, Renato Ramos; Fedorenko, Inna V; Sondak, Vernon K; Anderson, Alexander R. A; Kim, Eunjung; Amaravadi, Ravi K; Maria-Engler, Silvya Stuchi ; Messina, Jane L; Gibney, Geoffrey T; Kudchadkar, Ragini R; Smalley, Keiran S. M
Source: Pigment Cell Melanoma Research. Unidade: FCF
Subjects: QUIMIOTERAPIA, MELANOMA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBECCA, Vito William et al. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, v. 27, n. 3, p. 465-478, 2014Tradução . . Disponível em: https://doi.org/10.1111/pcmr.12227. Acesso em: 17 nov. 2024.
APA
Rebecca, V. W., Massaro, R. R., Fedorenko, I. V., Sondak, V. K., Anderson, A. R. A., Kim, E., et al. (2014). Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, 27( 3), 465-478. doi:10.1111/pcmr.12227
NLM
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/pcmr.12227
Vancouver
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/pcmr.12227
Trabalho de evento-resumo periodico
BRAF wild-type melanoma survival hinges upon AKT activity and adaptive autophagic reprogramming in response to chemotherapy (2013)
Rebecca, Vito William; Massaro, Raquel; Fedorenko, Inna V; Gibney, Geoffrey T; Sondak, Vernon K; Amaravadi, Ravi K; Kin, S; Maria-Engler, Silvya Stuchi ; Kudchadkar, Ragini; Smalley, K
Source: Pigment Cell & Melanoma Research. Conference titles: International Congress of the Society for Melanoma Research. Unidade: FCF
Subjects: MELANOMA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBECCA, Vito William et al. BRAF wild-type melanoma survival hinges upon AKT activity and adaptive autophagic reprogramming in response to chemotherapy. Pigment Cell & Melanoma Research. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2013
APA
Rebecca, V. W., Massaro, R., Fedorenko, I. V., Gibney, G. T., Sondak, V. K., Amaravadi, R. K., et al. (2013). BRAF wild-type melanoma survival hinges upon AKT activity and adaptive autophagic reprogramming in response to chemotherapy. Pigment Cell & Melanoma Research. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Rebecca VW, Massaro R, Fedorenko IV, Gibney GT, Sondak VK, Amaravadi RK, Kin S, Maria-Engler SS, Kudchadkar R, Smalley K. BRAF wild-type melanoma survival hinges upon AKT activity and adaptive autophagic reprogramming in response to chemotherapy. Pigment Cell & Melanoma Research. 2013 ; 26( 6): 991.[citado 2024 nov. 17 ]
Vancouver
Rebecca VW, Massaro R, Fedorenko IV, Gibney GT, Sondak VK, Amaravadi RK, Kin S, Maria-Engler SS, Kudchadkar R, Smalley K. BRAF wild-type melanoma survival hinges upon AKT activity and adaptive autophagic reprogramming in response to chemotherapy. Pigment Cell & Melanoma Research. 2013 ; 26( 6): 991.[citado 2024 nov. 17 ]
Artigo de periodico
Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach (2013)
Kim, Eunjung; Rebecca, Vito William; Fedorenko, Inna V; Messina, Jane L; Mathew, Rahel; Maria-Engler, Silvya Stuchi ; Basanta, David; Smalley, Keiran S. M; Anderson, Alexander R. A
Source: Cancer Research. Unidade: FCF
Subjects: FIBROBLASTOS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIM, Eunjung et al. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Research, v. 73, n. 23, p. 6874-6885, 2013Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.can-13-1720. Acesso em: 17 nov. 2024.
APA
Kim, E., Rebecca, V. W., Fedorenko, I. V., Messina, J. L., Mathew, R., Maria-Engler, S. S., et al. (2013). Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Research, 73( 23), 6874-6885. doi:10.1158/0008-5472.can-13-1720
NLM
Kim E, Rebecca VW, Fedorenko IV, Messina JL, Mathew R, Maria-Engler SS, Basanta D, Smalley KSM, Anderson ARA. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach [Internet]. Cancer Research. 2013 ; 73( 23): 6874-6885.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1158/0008-5472.can-13-1720
Vancouver
Kim E, Rebecca VW, Fedorenko IV, Messina JL, Mathew R, Maria-Engler SS, Basanta D, Smalley KSM, Anderson ARA. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach [Internet]. Cancer Research. 2013 ; 73( 23): 6874-6885.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1158/0008-5472.can-13-1720

USP Schools

ReP

Filtros

Authors

Non normalized affiliation